270 related articles for article (PubMed ID: 29899271)
1. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
Paul B; Li Y; Tollefsbol TO
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899271
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
Sharma M; Tollefsbol TO
Exp Cell Res; 2022 Jul; 416(1):113160. PubMed ID: 35447103
[TBL] [Abstract][Full Text] [Related]
3. Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms.
Royston KJ; Paul B; Nozell S; Rajbhandari R; Tollefsbol TO
Exp Cell Res; 2018 Jul; 368(1):67-74. PubMed ID: 29689276
[TBL] [Abstract][Full Text] [Related]
4. A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells.
Royston KJ; Udayakumar N; Lewis K; Tollefsbol TO
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534825
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase activity and vitamin D-dependent gene expressions in relation to sulforaphane in human breast cancer cells.
Hossain S; Liu Z; Wood RJ
J Food Biochem; 2020 Feb; 44(2):e13114. PubMed ID: 31846091
[TBL] [Abstract][Full Text] [Related]
6. Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition.
Tortorella SM; Royce SG; Licciardi PV; Karagiannis TC
Antioxid Redox Signal; 2015 Jun; 22(16):1382-424. PubMed ID: 25364882
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression.
Wang J; Tian KY; Fang Y; Chang HM; Han YN; Chen FQ
Int J Immunopathol Pharmacol; 2021; 35():20587384211034086. PubMed ID: 34344210
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation.
Martin SL; Kala R; Tollefsbol TO
Curr Cancer Drug Targets; 2018; 18(1):97-106. PubMed ID: 28176652
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane-cisplatin combination inhibits the stemness and metastatic potential of TNBCs via down regulation of sirtuins-mediated EMT signaling axis.
Sinha S; Sharma S; Sharma A; Vora J; Shrivastava N
Phytomedicine; 2021 Apr; 84():153492. PubMed ID: 33640782
[TBL] [Abstract][Full Text] [Related]
10. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.
Myzak MC; Karplus PA; Chung FL; Dashwood RH
Cancer Res; 2004 Aug; 64(16):5767-74. PubMed ID: 15313918
[TBL] [Abstract][Full Text] [Related]
11. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
Kala R; Shah HN; Martin SL; Tollefsbol TO
BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
Li Y; Meeran SM; Patel SN; Chen H; Hardy TM; Tollefsbol TO
Mol Cancer; 2013 Feb; 12():9. PubMed ID: 23379261
[TBL] [Abstract][Full Text] [Related]
14. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention.
Ho E; Clarke JD; Dashwood RH
J Nutr; 2009 Dec; 139(12):2393-6. PubMed ID: 19812222
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
Meeran SM; Patel SN; Tollefsbol TO
PLoS One; 2010 Jul; 5(7):e11457. PubMed ID: 20625516
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
Clarke JD; Hsu A; Yu Z; Dashwood RH; Ho E
Mol Nutr Food Res; 2011 Jul; 55(7):999-1009. PubMed ID: 21374800
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly.
Rajendran P; Delage B; Dashwood WM; Yu TW; Wuth B; Williams DE; Ho E; Dashwood RH
Mol Cancer; 2011 May; 10():68. PubMed ID: 21624135
[TBL] [Abstract][Full Text] [Related]
18. Dietary histone deacetylase inhibitors: from cells to mice to man.
Dashwood RH; Ho E
Semin Cancer Biol; 2007 Oct; 17(5):363-9. PubMed ID: 17555985
[TBL] [Abstract][Full Text] [Related]
19. A novel combinatorial approach using sulforaphane- and withaferin A-rich extracts for prevention of estrogen receptor-negative breast cancer through epigenetic and gut microbial mechanisms.
Rahman MM; Wu H; Tollefsbol TO
Sci Rep; 2024 May; 14(1):12091. PubMed ID: 38802425
[TBL] [Abstract][Full Text] [Related]
20. Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.
Ray A; Alalem M; Ray BK
J Biol Chem; 2013 Sep; 288(38):27232-27242. PubMed ID: 23926105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
